| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.724 | 0.005 | 0.726 | Anticonvulsant | 0.726 0.005 CID_89657 0.523 0.011 CID_14275474 | CID_89657 | |
| 0.541 | 0.002 | 0.541 | Benzodiazepine agonist | 0.342 0.003 CID_89657 0.251 0.004 CID_14275474 | ||
| 0.535 | 0.018 | 0.559 | GABA C receptor rho-3 antagonist | 0.46 0.038 CID_89657 0.559 0.013 CID_14275474 | CID_14275474 | |
| 0.476 | 0.034 | 0.476 | Thioredoxin glutathione reductase inhibitor | 0.462 0.037 CID_89657 0.434 0.045 CID_14275474 | ||
| 0.433 | 0.042 | 0.63 | Aldehyde oxidase inhibitor | 0.448 0.04 CID_89657 0.63 0.015 CID_14275474 | CID_14275474 | |
| 0.395 | 0.023 | 0.395 | Psychostimulant | 0.313 0.039 CID_89657 0.376 0.027 CID_14275474 | ||
| 0.407 | 0.037 | 0.407 | Nootropic | 0.274 0.089 CID_89657 0.28 0.085 CID_14275474 | ||
| 0.37 | 0.005 | 0.37 | GABA receptor agonist | 0.249 0.01 CID_89657 0.298 0.006 CID_14275474 | ||
| 0.335 | 0.033 | 0.335 | Sigma receptor agonist | 0.312 0.037 CID_14275474 | ||
| 0.317 | 0.023 | 0.317 | Gastrin inhibitor | 0.287 0.042 CID_89657 0.273 0.055 CID_14275474 | ||
| 0.394 | 0.106 | 0.453 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.453 0.059 CID_89657 0.268 0.259 CID_14275474 | CID_89657 | |
| 0.369 | 0.089 | 0.489 | 15-Lipoxygenase inhibitor | 0.357 0.096 CID_89657 0.489 0.043 CID_14275474 | CID_14275474 | |
| 0.324 | 0.083 | 0.334 | Thyroid hormone antagonist | 0.28 0.105 CID_89657 0.334 0.079 CID_14275474 | CID_14275474 | |
| 0.285 | 0.053 | 0.285 | 5 Hydroxytryptamine uptake stimulant | 0.258 0.074 CID_89657 0.277 0.058 CID_14275474 | ||
| 0.222 | 0.004 | 0.229 | Nociceptin (N/OFQ) receptor antagonist | 0.229 0.004 CID_89657 0.155 0.004 CID_14275474 | CID_89657 | |
| 0.238 | 0.028 | 0.238 | Polo-like kinase-3 inhibitor | 0.192 0.05 CID_14275474 | ||
| 0.258 | 0.06 | 0.318 | Cyclic AMP phosphodiesterase inhibitor | 0.318 0.035 CID_89657 0.269 0.055 CID_14275474 | CID_89657 | |
| 0.197 | 0.005 | 0.197 | Acetylcholine release stimulant | 0.13 0.034 CID_89657 0.153 0.015 CID_14275474 | ||
| 0.221 | 0.038 | 0.221 | Cytidine deaminase inhibitor | 0.165 0.065 CID_14275474 | ||
| 0.192 | 0.017 | 0.216 | 5 Hydroxytryptamine 3A agonist | 0.216 0.011 CID_89657 0.172 0.025 CID_14275474 | CID_89657 | |
| 0.234 | 0.061 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.249 0.05 CID_89657 0.25 0.049 CID_14275474 | CID_14275474 | |
| 0.213 | 0.04 | 0.237 | Diuretic | 0.237 0.033 CID_89657 0.185 0.051 CID_14275474 | CID_89657 | |
| 0.23 | 0.059 | 0.249 | Anesthetic general | 0.193 0.078 CID_89657 0.249 0.051 CID_14275474 | CID_14275474 | |
| 0.279 | 0.114 | 0.324 | Calcium channel activator | 0.324 0.069 CID_89657 0.261 0.134 CID_14275474 | CID_89657 | |
| 0.165 | 0.005 | 0.165 | Cholecystokinin A antagonist | 0.075 0.013 CID_89657 0.093 0.01 CID_14275474 | ||
| 0.163 | 0.005 | 0.163 | Bromodomain-containing protein 2 inhibitor | 0.146 0.01 CID_89657 0.133 0.015 CID_14275474 | ||
| 0.312 | 0.156 | 0.339 | DNA directed DNA polymerase inhibitor | 0.272 0.178 CID_89657 0.339 0.143 CID_14275474 | CID_14275474 | |
| 0.163 | 0.008 | 0.163 | 5 Hydroxytryptamine 3 antagonist | 0.064 0.032 CID_89657 0.058 0.037 CID_14275474 | ||
| 0.312 | 0.159 | 0.325 | DNA polymerase beta inhibitor | 0.282 0.175 CID_89657 0.325 0.152 CID_14275474 | CID_14275474 | |
| 0.283 | 0.133 | 0.406 | Histamine release inhibitor | 0.406 0.073 CID_89657 0.373 0.089 CID_14275474 | CID_89657 | |
| 0.186 | 0.038 | 0.186 | GABA C receptor rho-2 antagonist | 0.169 0.052 CID_89657 0.178 0.044 CID_14275474 | ||
| 0.198 | 0.05 | 0.272 | Heat shock protein 90 alpha antagonist | 0.213 0.042 CID_89657 0.272 0.02 CID_14275474 | CID_14275474 | |
| 0.236 | 0.09 | 0.25 | 5 Hydroxytryptamine 1E antagonist | 0.25 0.075 CID_89657 0.226 0.102 CID_14275474 | CID_89657 | |
| 0.192 | 0.046 | 0.192 | Acetylcholine M1 receptor antagonist | 0.171 0.058 CID_89657 0.187 0.048 CID_14275474 | ||
| 0.168 | 0.028 | 0.169 | Pregnane X receptor agonist | 0.169 0.027 CID_89657 0.16 0.038 CID_14275474 | CID_89657 | |
| 0.144 | 0.005 | 0.144 | Cholecystokinin antagonist | 0.064 0.016 CID_89657 0.073 0.013 CID_14275474 | ||
| 0.154 | 0.021 | 0.192 | Androgen antagonist | 0.135 0.027 CID_89657 0.192 0.014 CID_14275474 | CID_14275474 | |
| 0.135 | 0.005 | 0.135 | Purinergic P2X antagonist | 0.131 0.005 CID_89657 0.075 0.015 CID_14275474 | ||
| 0.275 | 0.145 | 0.275 | Beta lactamase inhibitor | 0.195 0.189 CID_89657 | ||
| 0.168 | 0.04 | 0.38 | Glutamate receptor antagonist | 0.38 0.005 CID_89657 0.161 0.044 CID_14275474 | CID_89657 | |
| 0.135 | 0.012 | 0.135 | Purinergic P2 antagonist | 0.129 0.013 CID_89657 0.082 0.031 CID_14275474 | ||
| 0.143 | 0.023 | 0.158 | Acetylcholine M3 receptor agonist | 0.158 0.015 CID_89657 0.088 0.053 CID_14275474 | CID_89657 | |
| 0.261 | 0.142 | 0.261 | Calpain 2 inhibitor | 0.22 0.171 CID_89657 0.197 0.19 CID_14275474 | ||
| 0.221 | 0.105 | 0.223 | 5 Hydroxytryptamine release stimulant | 0.223 0.104 CID_89657 0.223 0.104 CID_14275474 | CID_14275474 | |
| 0.139 | 0.024 | 0.139 | Electrolyte absorption antagonist | 0.12 0.036 CID_89657 0.11 0.046 CID_14275474 | ||
| 0.17 | 0.055 | 0.256 | Heat shock protein 90 antagonist | 0.206 0.035 CID_89657 0.256 0.019 CID_14275474 | CID_14275474 | |
| 0.117 | 0.004 | 0.117 | Corticotropin releasing factor 2 receptor antagonist | 0.109 0.005 CID_89657 0.079 0.018 CID_14275474 | ||
| 0.141 | 0.029 | 0.141 | Acetylcholine agonist | 0.126 0.034 CID_89657 | ||
| 0.119 | 0.011 | 0.119 | Acetylcholine M5 receptor agonist | 0.104 0.018 CID_89657 0.073 0.04 CID_14275474 | ||
| 0.214 | 0.108 | 0.214 | Interleukin agonist | 0.201 0.12 CID_89657 0.204 0.117 CID_14275474 | ||
| 0.109 | 0.004 | 0.438 | Purinergic P2X4 antagonist | 0.438 0.002 CID_89657 0.123 0.004 CID_14275474 | CID_89657 | |
| 0.116 | 0.013 | 0.116 | GABA A receptor antagonist | 0.093 0.018 CID_89657 0.088 0.019 CID_14275474 | ||
| 0.169 | 0.073 | 0.175 | ATPase inhibitor | 0.175 0.064 CID_89657 0.173 0.066 CID_14275474 | CID_89657 | |
| 0.208 | 0.113 | 0.236 | Spasmolytic | 0.187 0.131 CID_89657 0.236 0.097 CID_14275474 | CID_14275474 | |
| 0.108 | 0.014 | 0.108 | GABA receptor antagonist | 0.09 0.018 CID_89657 0.084 0.02 CID_14275474 | ||
| 0.146 | 0.054 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 CID_89657 0.145 0.056 CID_14275474 | ||
| 0.113 | 0.022 | 0.164 | Glycine receptor antagonist | 0.164 0.005 CID_89657 0.092 0.041 CID_14275474 | CID_89657 | |
| 0.098 | 0.008 | 0.119 | MDM2 inhibitor | 0.119 0.004 CID_89657 0.081 0.018 CID_14275474 | CID_89657 | |
| 0.152 | 0.063 | 0.152 | Mannose-6-phosphate isomerase inhibitor | 0.135 0.08 CID_89657 0.143 0.07 CID_14275474 | ||
| 0.116 | 0.032 | 0.116 | Polo-like kinase-1 inhibitor | 0.092 0.059 CID_14275474 | ||
| 0.097 | 0.016 | 0.143 | Phospholipase D inhibitor | 0.143 0.004 CID_89657 0.076 0.042 CID_14275474 | CID_89657 | |
| 0.115 | 0.034 | 0.115 | Histamine N-methyltransferase inhibitor | 0.105 0.041 CID_89657 0.106 0.041 CID_14275474 | ||
| 0.105 | 0.024 | 0.107 | Acetylcholine M4 receptor antagonist | 0.107 0.024 CID_89657 | CID_89657 | |
| 0.097 | 0.016 | 0.097 | 5 Hydroxytryptamine 3 agonist | 0.071 0.034 CID_89657 0.074 0.031 CID_14275474 | ||
| 0.219 | 0.139 | 0.219 | Thyroid hormone beta antagonist | 0.18 0.173 CID_89657 0.217 0.141 CID_14275474 | ||
| 0.093 | 0.015 | 0.093 | MAP kinase 7 inhibitor | 0.082 0.038 CID_14275474 | ||
| 0.181 | 0.104 | 0.202 | 5 Hydroxytryptamine 3E antagonist | 0.202 0.059 CID_89657 | CID_89657 | |
| 0.1 | 0.025 | 0.1 | Polo-like kinase-2 inhibitor | 0.074 0.049 CID_14275474 | ||
| 0.121 | 0.047 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 CID_89657 0.119 0.05 CID_14275474 | ||
| 0.081 | 0.007 | 0.081 | 5 Hydroxytryptamine 3B antagonist | 0.037 0.024 CID_89657 0.036 0.025 CID_14275474 | ||
| 0.078 | 0.005 | 0.084 | Parathyroid hormone antagonist | 0.084 0.004 CID_89657 0.066 0.008 CID_14275474 | CID_89657 | |
| 0.283 | 0.213 | 0.343 | Caspase 9 stimulant | 0.333 0.16 CID_89657 0.343 0.151 CID_14275474 | CID_14275474 | |
| 0.074 | 0.004 | 0.108 | Nociceptin (N/OFQ) receptor agonist | 0.108 0.004 CID_89657 0.044 0.006 CID_14275474 | CID_89657 | |
| 0.075 | 0.006 | 0.075 | Cholecystokinin B antagonist | 0.032 0.02 CID_89657 0.038 0.015 CID_14275474 | ||
| 0.218 | 0.149 | 0.282 | Cholesterol antagonist | 0.243 0.13 CID_89657 0.282 0.103 CID_14275474 | CID_14275474 | |
| 0.134 | 0.067 | 0.186 | NADPH oxidase inhibitor | 0.141 0.061 CID_89657 0.186 0.039 CID_14275474 | CID_14275474 | |
| 0.122 | 0.056 | 0.223 | Cystathionine beta-synthase inhibitor | 0.223 0.019 CID_14275474 | CID_14275474 | |
| 0.269 | 0.203 | 0.409 | 5 Hydroxytryptamine release inhibitor | 0.409 0.073 CID_89657 0.291 0.176 CID_14275474 | CID_89657 | |
| 0.2 | 0.136 | 0.251 | Tyrosine 3 hydroxylase inhibitor | 0.205 0.127 CID_89657 0.251 0.067 CID_14275474 | CID_14275474 | |
| 0.088 | 0.024 | 0.088 | 5 Hydroxytryptamine 3A antagonist | 0.061 0.055 CID_89657 | ||
| 0.126 | 0.062 | 0.126 | 5 Hydroxytryptamine antagonist | |||
| 0.082 | 0.018 | 0.082 | Bromodomain-containing protein 4 inhibitor | 0.054 0.038 CID_14275474 | ||
| 0.118 | 0.055 | 0.126 | Ferrochelatase inhibitor | 0.126 0.05 CID_89657 | CID_89657 | |
| 0.119 | 0.057 | 0.119 | Sphingosine 1-phosphate receptor 2 agonist | 0.113 0.068 CID_14275474 | ||
| 0.154 | 0.097 | 0.182 | Amyloid beta precursor protein antagonist | 0.182 0.07 CID_14275474 | CID_14275474 | |
| 0.163 | 0.106 | 0.163 | MAP kinase kinase 5 inhibitor | 0.161 0.113 CID_89657 | ||
| 0.106 | 0.051 | 0.159 | Potassium channel (Ca-activated) activator | 0.11 0.047 CID_89657 0.159 0.025 CID_14275474 | CID_14275474 | |
| 0.156 | 0.101 | 0.174 | Succinate dehydrogenase inhibitor | 0.174 0.075 CID_89657 0.168 0.084 CID_14275474 | CID_89657 | |
| 0.077 | 0.023 | 0.077 | Acetylcholine muscarinic agonist | 0.062 0.032 CID_89657 | ||
| 0.078 | 0.025 | 0.097 | Androgen agonist | 0.077 0.025 CID_89657 0.097 0.016 CID_14275474 | CID_14275474 | |
| 0.072 | 0.02 | 0.16 | AMPA receptor antagonist | 0.16 0.005 CID_89657 0.062 0.024 CID_14275474 | CID_89657 | |
| 0.068 | 0.019 | 0.068 | 5 Hydroxytryptamine 4 antagonist | 0.061 0.023 CID_89657 0.05 0.038 CID_14275474 | ||
| 0.203 | 0.154 | 0.235 | Prostaglandin dehydrogenase inhibitor | 0.235 0.135 CID_14275474 | CID_14275474 | |
| 0.058 | 0.014 | 0.058 | Glutamate (mGluR group III) antagonist | 0.05 0.021 CID_89657 0.048 0.023 CID_14275474 | ||
| 0.078 | 0.034 | 0.123 | Dopamine D1 antagonist | 0.062 0.047 CID_89657 0.123 0.019 CID_14275474 | CID_14275474 | |
| 0.094 | 0.051 | 0.102 | NADH dehydrogenase inhibitor | 0.102 0.042 CID_89657 0.102 0.042 CID_14275474 | CID_14275474 | |
| 0.057 | 0.016 | 0.057 | Benzodiazepine antagonist | 0.048 0.032 CID_89657 | ||
| 0.124 | 0.082 | 0.124 | Toll-Like receptor 9 antagonist | |||
| 0.191 | 0.15 | 0.3 | Lipoxygenase inhibitor | 0.3 0.071 CID_14275474 | CID_14275474 | |
| 0.085 | 0.045 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | 0.074 0.057 CID_89657 | ||
| 0.079 | 0.042 | 0.079 | Vanilloid 4 agonist | 0.071 0.062 CID_89657 | ||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | 0.096 0.067 CID_89657 0.089 0.08 CID_14275474 | ||
| 0.062 | 0.027 | 0.065 | Acetylcholine M2 receptor agonist | 0.065 0.023 CID_89657 | CID_89657 | |
| 0.098 | 0.063 | 0.098 | Insulin receptor antagonist | 0.09 0.076 CID_89657 | ||
| 0.047 | 0.012 | 0.047 | Acetylcholine M4 receptor agonist | 0.039 0.015 CID_89657 | ||
| 0.057 | 0.023 | 0.057 | Bromodomain-containing protein 3 inhibitor | 0.046 0.04 CID_89657 | ||
| 0.056 | 0.023 | 0.056 | Acetylcholine M1 receptor agonist | 0.045 0.028 CID_89657 | ||
| 0.047 | 0.015 | 0.05 | p53 inhibitor | 0.05 0.014 CID_89657 0.032 0.029 CID_14275474 | CID_89657 | |
| 0.161 | 0.129 | 0.194 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.194 0.103 CID_89657 0.18 0.113 CID_14275474 | CID_89657 | |
| 0.069 | 0.037 | 0.072 | Dopamine D4 antagonist | 0.072 0.035 CID_89657 | CID_89657 | |
| 0.071 | 0.04 | 0.071 | Glutamate (mGluR7) antagonist | 0.065 0.052 CID_14275474 | ||
| 0.081 | 0.052 | 0.081 | Glutamate receptor agonist | |||
| 0.044 | 0.015 | 0.052 | CF transmembrane conductance regulator antagonist | 0.043 0.019 CID_89657 0.052 0.007 CID_14275474 | CID_14275474 | |
| 0.092 | 0.063 | 0.134 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.134 0.032 CID_89657 | CID_89657 | |
| 0.048 | 0.02 | 0.048 | Nerve growth factor antagonist | 0.042 0.03 CID_89657 | ||
| 0.138 | 0.11 | 0.151 | Antipruritic | 0.151 0.093 CID_89657 0.133 0.117 CID_14275474 | CID_89657 | |
| 0.093 | 0.065 | 0.093 | Phosphodiesterase 7B inhibitor | |||
| 0.085 | 0.059 | 0.291 | NMDA receptor antagonist | 0.291 0.007 CID_89657 0.141 0.027 CID_14275474 | CID_89657 | |
| 0.04 | 0.015 | 0.043 | Potassium channel small-conductance Ca-activated activator | 0.043 0.013 CID_89657 | CID_89657 | |
| 0.048 | 0.022 | 0.052 | GABA B receptor antagonist | 0.052 0.018 CID_89657 0.042 0.031 CID_14275474 | CID_89657 | |
| 0.05 | 0.025 | 0.05 | Glutamate (mGluR5) agonist | |||
| 0.084 | 0.06 | 0.118 | Antineoplastic alkaloid | 0.118 0.038 CID_14275474 | CID_14275474 | |
| 0.082 | 0.058 | 0.082 | Caspase 7 inhibitor | |||
| 0.071 | 0.048 | 0.071 | HIV-1 reverse transcriptase inhibitor | 0.06 0.059 CID_14275474 | ||
| 0.092 | 0.069 | 0.105 | Bile acid receptor antagonist | 0.105 0.039 CID_14275474 | CID_14275474 | |
| 0.034 | 0.012 | 0.034 | LFA antagonist | 0.025 0.024 CID_14275474 | ||
| 0.089 | 0.067 | 0.107 | Protein kinase C zeta inhibitor | 0.104 0.046 CID_89657 0.107 0.043 CID_14275474 | CID_14275474 | |
| 0.061 | 0.039 | 0.061 | Phosphodiesterase 1A inhibitor | 0.059 0.043 CID_89657 | ||
| 0.15 | 0.131 | 0.239 | Focal adhesion kinase 2 inhibitor | 0.239 0.043 CID_89657 | CID_89657 | |
| 0.153 | 0.134 | 0.194 | Aryl hydrocarbon receptor agonist | 0.194 0.106 CID_89657 0.151 0.135 CID_14275474 | CID_89657 | |
| 0.153 | 0.134 | 0.154 | Histone acetyltransferase inhibitor | 0.154 0.133 CID_89657 | CID_89657 | |
| 0.226 | 0.207 | 0.226 | Analgesic | |||
| 0.151 | 0.134 | 0.151 | Potassium channel blocker | |||
| 0.168 | 0.152 | 0.22 | MAP-kinase-activated kinase 5 inhibitor | 0.22 0.082 CID_89657 0.174 0.142 CID_14275474 | CID_89657 | |
| 0.103 | 0.087 | 0.103 | Acetylcholine muscarinic antagonist | 0.101 0.09 CID_14275474 | ||
| 0.076 | 0.061 | 0.076 | Histamine H1 receptor antagonist | |||
| 0.069 | 0.054 | 0.069 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.087 | 0.074 | 0.113 | DNA directed RNA polymerase inhibitor | 0.113 0.043 CID_89657 | CID_89657 | |
| 0.061 | 0.049 | 0.061 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.109 | 0.099 | 0.109 | Sodium channel (voltage-gated) blocker | |||
| 0.041 | 0.031 | 0.053 | Dopamine D5 antagonist | 0.053 0.023 CID_14275474 | CID_14275474 | |
| 0.05 | 0.04 | 0.05 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.027 | 0.019 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.026 | 0.018 | 0.026 | Acid ceramidase inhibitor | |||
| 0.122 | 0.115 | 0.158 | Cyclin-dependent kinase 8 inhibitor | 0.158 0.072 CID_89657 | CID_89657 | |
| 0.022 | 0.015 | 0.022 | Geranylgeranyltransferase inhibitor | |||
| 0.078 | 0.074 | 0.078 | T cell inhibitor | |||
| 0.059 | 0.055 | 0.059 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.042 | 0.04 | 0.042 | Glutamate (mGluR group I) agonist | |||
| 0.04 | 0.039 | 0.04 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.092 | 0.091 | 0.111 | GABA C receptor antagonist | 0.111 0.063 CID_89657 | CID_89657 | |
| 0.014 | 0.013 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.011 CID_14275474 | CID_14275474 | |
| 0.075 | 0.074 | 0.075 | GABA A receptor agonist | |||
| 0.055 | 0.056 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.071 0.027 CID_89657 0.068 0.03 CID_14275474 | CID_89657 | |
| 0.065 | 0.066 | 0.066 | Glycine receptor agonist | 0.066 0.064 CID_89657 | CID_89657 | |
| 0.02 | 0.022 | 0.093 | NMDA receptor glycine site antagonist | 0.093 0.004 CID_89657 | CID_89657 | |
| 0.052 | 0.055 | 0.126 | NMDA receptor glycine site agonist | 0.126 0.007 CID_89657 | CID_89657 | |
| 0.157 | 0.161 | 0.219 | ErbB-1 antagonist | 0.219 0.071 CID_89657 0.168 0.137 CID_14275474 | CID_89657 | |
| 0.012 | 0.015 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.008 CID_14275474 | CID_14275474 | |
| 0.05 | 0.054 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.039 CID_89657 | CID_89657 | |
| 0.051 | 0.057 | 0.079 | 5 Hydroxytryptamine 2A agonist | 0.079 0.028 CID_89657 | CID_89657 | |
| 0.085 | 0.094 | 0.113 | Polo-like kinase-4 inhibitor | 0.113 0.063 CID_89657 | CID_89657 | |
| 0.127 | 0.137 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.089 CID_14275474 | CID_14275474 | |
| 0.088 | 0.1 | 0.099 | Protein kinase C gamma inhibitor | 0.099 0.078 CID_89657 0.093 0.091 CID_14275474 | CID_89657 | |
| 0.05 | 0.062 | 0.054 | Pregnane X receptor antagonist | 0.054 0.049 CID_89657 | CID_89657 | |
| 0.078 | 0.09 | 0.143 | Creatine kinase inhibitor | 0.143 0.027 CID_14275474 | CID_14275474 | |
| 0.041 | 0.053 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.018 CID_89657 | CID_89657 | |
| 0.042 | 0.055 | 0.06 | Potassium channel (Inward rectifier) activator | 0.06 0.019 CID_89657 | CID_89657 | |
| 0.162 | 0.175 | 0.234 | Nitric-oxide synthase stimulant | 0.234 0.045 CID_89657 0.181 0.127 CID_14275474 | CID_89657 | |
| 0.079 | 0.093 | 0.09 | Lanosterol 14 alpha demethylase inhibitor | 0.09 0.071 CID_89657 | CID_89657 | |
| 0.083 | 0.098 | 0.087 | Phosphodiesterase 6D inhibitor | 0.087 0.084 CID_14275474 | CID_14275474 | |
| 0.02 | 0.036 | 0.026 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.022 CID_14275474 | CID_14275474 | |
| 0.129 | 0.145 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | 0.141 0.118 CID_89657 | CID_89657 | |
| 0.073 | 0.092 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.043 CID_14275474 | CID_14275474 | |
| 0.024 | 0.044 | 0.042 | Antidiuretic hormone antagonist | 0.042 0.026 CID_89657 | CID_89657 | |
| 0.022 | 0.043 | 0.073 | Kainate receptor 2 antagonist | 0.073 0.008 CID_89657 | CID_89657 | |
| 0.021 | 0.042 | 0.027 | Liver X receptor alpha antagonist | 0.027 0.025 CID_14275474 | CID_14275474 | |
| 0.037 | 0.06 | 0.061 | Aldosterone antagonist | 0.061 0.019 CID_89657 | CID_89657 | |
| 0.087 | 0.112 | 0.106 | Nav1.5 sodium channel blocker | 0.106 0.075 CID_89657 | CID_89657 | |
| 0.066 | 0.092 | 0.107 | Opioid antagonist | 0.107 0.043 CID_14275474 | CID_14275474 | |
| 0.015 | 0.041 | 0.025 | Vasopressin 1A antagonist | 0.025 0.023 CID_89657 | CID_89657 | |
| 0.034 | 0.061 | 0.056 | Glutamate (mGluR4) antagonist | 0.056 0.016 CID_89657 | CID_89657 | |
| 0.03 | 0.058 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.02 CID_89657 | CID_89657 | |
| 0.012 | 0.041 | 0.07 | AMPA 1 receptor antagonist | 0.07 0.008 CID_89657 | CID_89657 | |
| 0.046 | 0.08 | 0.117 | NMDA receptor agonist | 0.117 0.014 CID_89657 | CID_89657 | |
| 0.024 | 0.061 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.01 CID_89657 | CID_89657 | |
| 0.14 | 0.179 | 0.169 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.11 CID_14275474 | CID_14275474 | |
| 0.021 | 0.06 | 0.049 | NMDA receptor subunit 3A antagonist | 0.049 0.02 CID_89657 0.034 0.031 CID_14275474 | CID_89657 | |
| 0.014 | 0.054 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.011 CID_89657 | CID_89657 | |
| 0.047 | 0.087 | 0.089 | Prostaglandin-E synthase inhibitor | 0.089 0.033 CID_89657 | CID_89657 | |
| 0.025 | 0.066 | 0.039 | Opioid kappa receptor agonist | 0.039 0.036 CID_14275474 | CID_14275474 | |
| 0.014 | 0.056 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_89657 | CID_89657 | |
| 0.089 | 0.131 | 0.112 | Ribosomal protein S6 kinase inhibitor | 0.112 0.1 CID_89657 | CID_89657 | |
| 0.041 | 0.086 | 0.063 | Dihydroorotate oxidase inhibitor | 0.063 0.025 CID_89657 | CID_89657 | |
| 0.038 | 0.083 | 0.121 | NMDA 2C receptor antagonist | 0.121 0.01 CID_89657 | CID_89657 | |
| 0.065 | 0.111 | 0.085 | Potassium channel activator | 0.085 0.068 CID_89657 | CID_89657 | |
| 0.043 | 0.091 | 0.062 | Heat shock protein 90 beta antagonist | 0.062 0.037 CID_14275474 | CID_14275474 | |
| 0.031 | 0.08 | 0.056 | 5 Hydroxytryptamine 2 agonist | 0.056 0.031 CID_89657 | CID_89657 | |
| 0.028 | 0.076 | 0.051 | Opioid agonist | 0.051 0.039 CID_14275474 | CID_14275474 | |
| 0.026 | 0.075 | 0.064 | NMDA receptor subunit 3B antagonist | 0.064 0.017 CID_89657 0.039 0.037 CID_14275474 | CID_89657 | |
| 0.125 | 0.18 | 0.176 | Neurotrophic factor enhancer | 0.156 0.13 CID_89657 0.176 0.102 CID_14275474 | CID_14275474 | |
| 0.164 | 0.221 | 0.199 | Vasodilator, peripheral | 0.199 0.177 CID_89657 | CID_89657 | |
| 0.029 | 0.089 | 0.111 | Glutamate (mGluR1) antagonist | 0.111 0.013 CID_89657 | CID_89657 | |
| 0.026 | 0.088 | 0.041 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 CID_89657 | CID_89657 | |
| 0.041 | 0.106 | 0.168 | Cyclin B3 inhibitor | 0.168 0.01 CID_89657 | CID_89657 | |
| 0.01 | 0.074 | 0.022 | Kainate receptor 4 antagonist | 0.022 0.02 CID_89657 | CID_89657 | |
| 0.005 | 0.07 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 CID_89657 | CID_89657 | |
| 0.023 | 0.089 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 CID_89657 | CID_89657 | |
| 0.01 | 0.078 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 CID_89657 | CID_89657 | |
| 0.045 | 0.116 | 0.065 | Potassium channel large-conductance Ca-activated activator | 0.065 0.05 CID_14275474 | CID_14275474 | |
| 0.057 | 0.129 | 0.073 | GABA B receptor agonist | 0.073 0.058 CID_89657 | CID_89657 | |
| 0.062 | 0.135 | 0.086 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 CID_89657 | CID_89657 | |
| 0.094 | 0.171 | 0.126 | Hexokinase inhibitor | 0.126 0.11 CID_89657 | CID_89657 | |
| 0.014 | 0.092 | 0.053 | Kainate receptor antagonist | 0.053 0.02 CID_89657 | CID_89657 | |
| 0.052 | 0.131 | 0.083 | Opioid kappa receptor antagonist | 0.083 0.054 CID_14275474 | CID_14275474 | |
| 0.007 | 0.088 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.016 CID_89657 | CID_89657 | |
| 0.065 | 0.149 | 0.117 | MAP kinase 13 inhibitor | 0.117 0.058 CID_89657 | CID_89657 | |
| 0.144 | 0.23 | 0.21 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.14 CID_14275474 | CID_14275474 | |
| 0.104 | 0.19 | 0.138 | MAP kinase 3 inhibitor | 0.138 0.089 CID_89657 | CID_89657 | |
| 0.017 | 0.107 | 0.082 | NMDA 2A receptor antagonist | 0.082 0.019 CID_89657 | CID_89657 | |
| 0.019 | 0.11 | 0.039 | Estrogen-related receptor beta antagonist | 0.039 0.013 CID_14275474 | CID_14275474 | |
| 0.065 | 0.157 | 0.154 | AMP-activated protein kinase stimulant | 0.154 0.026 CID_89657 | CID_89657 | |
| 0.057 | 0.154 | 0.096 | GABA C receptor agonist | 0.096 0.071 CID_89657 | CID_89657 | |
| 0.063 | 0.162 | 0.127 | MAP kinase 12 inhibitor | 0.127 0.061 CID_89657 | CID_89657 | |
| 0.132 | 0.24 | 0.22 | 12-Lipoxygenase inhibitor | 0.22 0.131 CID_14275474 | CID_14275474 | |
| 0.114 | 0.222 | 0.157 | Neurotensin receptor agonist | 0.157 0.086 CID_89657 0.139 0.132 CID_14275474 | CID_89657 | |
| 0.061 | 0.173 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.072 CID_14275474 | CID_14275474 | |
| 0.079 | 0.201 | 0.108 | Interleukin 2 antagonist | 0.108 0.069 CID_89657 | CID_89657 | |
| 0.04 | 0.162 | 0.075 | Macrophage migration inhibitory factor inhibitor | 0.075 0.058 CID_14275474 | CID_14275474 | |
| 0.089 | 0.213 | 0.131 | Dual specificity phosphatase inhibitor | 0.131 0.119 CID_14275474 | CID_14275474 | |
| 0.021 | 0.149 | 0.13 | NMDA 2 receptor antagonist | 0.13 0.021 CID_89657 | CID_89657 | |
| 0.025 | 0.156 | 0.066 | MAP kinase 11 inhibitor | 0.066 0.059 CID_89657 | CID_89657 | |
| 0.009 | 0.143 | 0.034 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.034 0.026 CID_14275474 | CID_14275474 | |
| 0.035 | 0.17 | 0.069 | Glutamate (mGluR) antagonist | 0.069 0.062 CID_89657 | CID_89657 | |
| 0.131 | 0.284 | 0.227 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.227 0.128 CID_89657 | CID_89657 | |
| 0.132 | 0.286 | 0.222 | Alpha-glucosidase inhibitor | 0.222 0.204 CID_14275474 | CID_14275474 | |
| 0.172 | 0.33 | 0.317 | Calcium channel L-type activator | 0.253 0.202 CID_89657 0.317 0.143 CID_14275474 | CID_14275474 | |
| 0.121 | 0.297 | 0.189 | Neuropeptide Y2 antagonist | 0.189 0.141 CID_89657 | CID_89657 | |
| 0.109 | 0.287 | 0.201 | Transcription factor NF kappa B inhibitor | 0.201 0.168 CID_14275474 | CID_14275474 | |
| 0.181 | 0.362 | 0.272 | Antiinflammatory | 0.272 0.243 CID_14275474 | CID_14275474 | |
| 0.122 | 0.325 | 0.202 | Insulysin inhibitor | 0.202 0.154 CID_89657 | CID_89657 | |
| 0.157 | 0.37 | 0.243 | MAP kinase kinase 6 inhibitor | 0.243 0.199 CID_89657 | CID_89657 | |
| 0.04 | 0.269 | 0.09 | Beta glucuronidase inhibitor | 0.09 0.088 CID_89657 | CID_89657 | |
| 0.091 | 0.321 | 0.21 | Death-associated protein kinase 2 inhibitor | 0.21 0.028 CID_89657 | CID_89657 | |
| 0.127 | 0.367 | 0.247 | Interleukin 2 agonist | 0.247 0.121 CID_89657 | CID_89657 | |
| 0.013 | 0.266 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | 0.042 0.037 CID_89657 | CID_89657 | |
| 0.078 | 0.362 | 0.124 | Death-associated protein kinase 1 inhibitor | 0.124 0.098 CID_89657 | CID_89657 | |
| 0.03 | 0.335 | 0.133 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.133 0.09 CID_89657 | CID_89657 | |
| 0.005 | 0.323 | 0.034 | Factor XI inhibitor | 0.034 0.023 CID_89657 | CID_89657 | |
| 0.064 | 0.384 | 0.136 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.136 0.103 CID_89657 | CID_89657 | |
| 0.074 | 0.403 | 0.161 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.161 0.117 CID_89657 | CID_89657 | |
| 0.009 | 0.358 | 0.063 | Cyclin B2 inhibitor | 0.063 0.028 CID_89657 | CID_89657 | |
| 0.007 | 0.368 | 0.043 | Factor XIa inhibitor | 0.043 0.026 CID_89657 | CID_89657 | |
| 0.059 | 0.422 | 0.168 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.168 0.121 CID_89657 | CID_89657 | |
| 0.01 | 0.385 | 0.063 | Cyclin B1 inhibitor | 0.063 0.04 CID_89657 | CID_89657 | |
| 0.008 | 0.394 | 0.055 | Cyclin B inhibitor | 0.055 0.038 CID_89657 | CID_89657 | |
| 0.012 | 0.59 | 0.108 | Estrogen receptor beta antagonist | 0.108 0.049 CID_14275474 | CID_14275474 | |
| 0.014 | 0.647 | 0.117 | Estrogen antagonist | 0.117 0.061 CID_14275474 | CID_14275474 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |